# Gardasil Vaccination in Post Stem Cell Transplant Patients

> **NCT01092195** · PHASE1 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 64 (actual)

## Conditions studied

- Gardasil Vaccine
- Stem Cell Transplant
- Immunogenicity

## Interventions

- **BIOLOGICAL:** Gardasil

## Key facts

- **NCT ID:** NCT01092195
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06-02
- **Primary completion:** 2016-07-19
- **Final completion:** 2016-07-19
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2019-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01092195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01092195, "Gardasil Vaccination in Post Stem Cell Transplant Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01092195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*